Vantage Investment Advisors, LLC - Supreme Pharmaceuticals, Inc. ownership

Back to all holdings Add to watchlist

Supreme Pharmaceuticals, Inc.'s ticker is and the CUSIP is 868632209. A total of 1 filers reported holding Supreme Pharmaceuticals, Inc. in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Vantage Investment Advisors, LLC ownership history of Supreme Pharmaceuticals, Inc.
ValueSharesWeighting
Q2 2018$0–2000.0%0.00%–
Q1 2018$0–2000.0%0.00%–
Q4 2017$0–2000.0%0.00%–
Q3 2017$0–2000.0%0.00%–
Q2 2017$0–2000.0%0.00%–
Q1 2017$0–200–0.00%–
 Download
Other shareholders
Supreme Pharmaceuticals, Inc. shareholders Q2 2017
NameSharesValueWeighting ↓
BOSTON FINANCIAL MANGEMENT LLC 10,000$11,0000.00%
Vantage Investment Advisors, LLC 200$00.00%
View complete list of Supreme Pharmaceuticals, Inc. shareholders